Metformin (Longevity Context) — Frequently Asked Questions
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
Frequently Asked Questions
Can I take metformin for longevity without diabetes?
Can I take metformin for longevity without diabetes?
Metformin is a prescription medication approved only for type 2 diabetes. Off-label use for longevity requires a doctor's prescription and monitoring. Some longevity-focused physicians prescribe it based on observational data, but the TAME trial results (expected in the coming years) will provide the first definitive evidence for or against this practice. Do not attempt to obtain or use metformin without medical supervision.
Does metformin interfere with exercise benefits?
Does metformin interfere with exercise benefits?
A 2019 study by Konopka et al. found that metformin attenuated improvements in mitochondrial function and cardiorespiratory fitness from aerobic exercise in older adults. This has led some longevity practitioners to skip metformin on intense workout days or cycle it around training periods. The interaction between metformin and exercise is still being studied.
What is the TAME trial?
What is the TAME trial?
TAME (Targeting Aging with Metformin) is a landmark clinical trial led by Dr. Nir Barzilai at the Albert Einstein College of Medicine. It is the first FDA-approved trial designed to test whether a drug can slow the aging process itself, rather than treating a specific disease. Approximately 3,000 participants aged 65-79 will be tracked for age-related outcomes including cardiovascular disease, cancer, dementia, and mortality. Results are expected to shape the future of anti-aging medicine.
References
- Bannister CA, Holden SE, Jenkins-Jones S, et al. (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes, Obesity and Metabolism. DOI PubMed
- Gandini S, Puntoni M, Heckman-Stoddard BM, et al. (2014). Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prevention Research. DOI PubMed
- Konopka AR, Laurin JL, Schoenberg HM, et al. (2019). Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. DOI PubMed